iBio, Inc.
IBIO· Nasdaq
IBIOiBio, Inc.
Filed Nov 14, 2011 · 10-Q · 45 days after period end · 0000930413-11-007345
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $320.35K | — |
| Net Income | $383.14K | -$2.82M |
| EPS Diluted | $0.01 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 14, 2011 · 45 d after period end
